Olympiad Research LP Trims Stake in Cadre Holdings, Inc. $CDRE
by Jessica Moore · The Cerbat GemOlympiad Research LP cut its stake in Cadre Holdings, Inc. (NYSE:CDRE – Free Report) by 41.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,055 shares of the company’s stock after selling 4,902 shares during the period. Olympiad Research LP’s holdings in Cadre were worth $225,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Select Equity Group L.P. boosted its position in Cadre by 726.6% during the 1st quarter. Select Equity Group L.P. now owns 447,337 shares of the company’s stock valued at $13,246,000 after acquiring an additional 393,218 shares in the last quarter. Pembroke Management LTD acquired a new position in shares of Cadre during the first quarter valued at about $5,039,000. Fred Alger Management LLC grew its position in Cadre by 20.9% during the 1st quarter. Fred Alger Management LLC now owns 826,528 shares of the company’s stock worth $24,473,000 after purchasing an additional 143,119 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Cadre during the first quarter valued at $1,648,000. Finally, Northern Trust Corp increased its holdings in shares of Cadre by 14.9% in the first quarter. Northern Trust Corp now owns 344,693 shares of the company’s stock valued at $10,206,000 after purchasing an additional 44,588 shares during the period. 43.95% of the stock is owned by hedge funds and other institutional investors.
Cadre Trading Down 0.1%
NYSE CDRE opened at $43.19 on Friday. The firm has a market cap of $1.76 billion, a price-to-earnings ratio of 38.57, a PEG ratio of 1.54 and a beta of 1.36. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.58 and a current ratio of 3.64. Cadre Holdings, Inc. has a one year low of $27.07 and a one year high of $46.64. The firm has a 50 day simple moving average of $38.54 and a 200-day simple moving average of $34.56.
Cadre (NYSE:CDRE – Get Free Report) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. The company had revenue of $155.87 million for the quarter, compared to the consensus estimate of $158.96 million. Cadre had a net margin of 7.33% and a return on equity of 13.94%. The company’s quarterly revenue was up 42.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.09 EPS. Cadre has set its FY 2025 guidance at EPS. Equities research analysts anticipate that Cadre Holdings, Inc. will post 1.05 EPS for the current fiscal year.
Cadre Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 31st will be issued a $0.095 dividend. This represents a $0.38 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, October 31st. Cadre’s dividend payout ratio is presently 33.93%.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on CDRE shares. B. Riley restated a “buy” rating on shares of Cadre in a research report on Thursday, November 6th. Wall Street Zen upgraded Cadre from a “hold” rating to a “buy” rating in a research note on Saturday, November 1st. Lake Street Capital boosted their price target on Cadre from $41.00 to $43.00 and gave the company a “buy” rating in a report on Thursday, October 9th. Bank of America lowered Cadre from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $38.00 to $26.00 in a research report on Wednesday, August 13th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cadre in a report on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $37.67.
Get Our Latest Research Report on CDRE
Cadre Company Profile
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Stories
- Five stocks we like better than Cadre
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Monolithic Power Surges in 2025—Time to Buy or Hold?
- How to trade using analyst ratings
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- Why is the Ex-Dividend Date Significant to Investors?
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing